that disrupt protein−protein interactions is a key goal in addressing a number of disease states. The α-helix is commonly found at protein interaction interfaces and has been the focus of substantial small molecule mimetic efforts. One of the primary drawbacks of many small molecule α-helix mimetics is their hydrophobic core structures. To address this problem we have developed a novel scaffold based
开发破坏蛋白质-蛋白质相互作用的小分子是解决许多疾病状态的关键目标。α-螺旋常见于蛋白质相互作用界面,并且一直是大量小分子模拟工作的重点。许多小分子 α-螺旋模拟物的主要缺点之一是它们的疏
水核心结构。为了解决这个问题,我们开发了一种基于
水溶性更好的 5-6-5
咪唑-苯基-
噻唑核的新型支架。此类
抑制剂已被证明可以在微摩尔浓度下破坏 Cdc42/Dbs 蛋白-蛋白相互作用,并且可能有助于克服 Cdc42 诱导的肿瘤对抗癌疗法的耐药性。